Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux.
Pouplard
C
C
Couvret
C
C
Regina
S
S
Gruel
Y
Y
D000917:Antibody Formation; D001323:Autoantibodies / Q000097:blood*; D000077425:Fondaparinux; D006801:Humans; D019637:Orthopedic Procedures; D010978:Platelet Factor 4 / Q000276:immunology* / Q000378:metabolism*; D000071228:Polyelectrolytes; D011108:Polymers / Q000378:metabolism; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects*; D013927:Thrombosis / Q000139:chemically induced / Q000517:prevention & control
D001323:Autoantibodies; D000077425:Fondaparinux; D010978:Platelet Factor 4; D000071228:Polyelectrolytes; D011108:Polymers; D011134:Polysaccharides